SEARCH RESULTS FOR: "Tag: SRPT"
REFINE YOUR SEARCH:
RECENT
Last Month(1)
ARTICLES/BLOGS
2019(13)
2018(8)
2017(17)
2016(45)
2015(10)
2014(3)
CATEGORIES
Analyst Downgrades(4)
Analyst Update(13)
Analyst Upgrades(11)
Best and Worst Stocks(2)
Buzz Stocks(13)
By the Numbers(3)
Expectational Analysis(2)
General(4)
Indexes and ETFs(1)
Intraday Option Activity(15)
Midday Market Check(9)
Most Active Options Update(1)
Most Active Weekly Options(3)
Opening View(10)
Overseas Trading(1)
Quantitative Analysis(4)
Stock Market News(15)
Stocks On the Move(21)
Technical Analysis(2)
Unusual Trading Activity(1)

12/23/2019 9:11 AM
Fresh off a record-setting week, Dow Jones Industrial Average (DJI) futures are trending higher yet again. Fueling this morning's risk-on approach are trade tailwinds out of China, after the countr...
12/16/2019 2:37 PM
The shares of pharmaceutical concern Wave Life Sciences Ltd (NASDAQ:WVE) have more than halved today after the firm said it would be halting the development of its Duchenne muscular distrophy (DMD) d...
12/13/2019 11:31 AM
Drug maker Sarepta Therapeutics Inc (NASDAQ:SRPT) is soaring this morning, up 33% at $132.50. The company's Duchenne Muscular Dystrophy (DMD) treatment was approved by the Food and Drug Administration...
12/13/2019 9:23 AM
Fresh off reports of a "phase one" trade deal being drawn up, Dow Jones Industrial Average (DJI), S&P 500 Index (SPX), and Nasdaq-100 Index (NDX) futures are confidently higher today. But while Blo...
11/1/2019 12:06 PM
Sarepta Therapeutics Inc (NASDAQ:SRPT) stock is up 4.3% today to trade at $86.63, after Guggenheim initiated coverage with a "buy" rating and a $183 price target -- a 120% premium to last night's clos...
Partner Center